Topotecan-pazopanib combination thera...

Topotecan-pazopanib combination therapy for aggressive pediatric solid tumors

Posted in the Pediatric Cancer Forum


Madison, WI

#1 Jul 27, 2011
A recent study reported in the journal Clinical Cancer Research, metronomic administration of Topotecan and pazopanib showed a statistically significant antitumor activity compared to respective single agents in pediatric tumor mouse models and represent a valid option as a maintenance therapy in aggressive pediatric solid tumors. In vitro, Topotecan caused a dose-dependent decrease in viabilities of all cell lines, while pazopanib did not. In vivo, combination of Topotecan + Pazopanib (TP+PZ) demonstrated significant anti-tumor activity and significant enhancement in survival compared to the respective single agents in all models. Pharmacokinetic studies of both drugs did not reveal any drug-drug interaction. News link:

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Pediatric Cancer Discussions

Title Updated Last By Comments
News Genetic hallmarks of acute lymphoblastic leukem... Oct '16 Stephany McDowell 1
News Retired Ringling Bros. circus elephants have a ... Sep '16 Stephany McDowell 1
levitra forums, levitra coupons & levitra adver... (Apr '16) Apr '16 Hopkins 1
doctors urge halt on viagra production (Mar '16) Mar '16 Douglas 1
News Save the Chickens and the Children (Aug '15) Aug '15 Gof print 1
News Trusted Translations Launches 'Translation for ... (Jun '09) Jun '15 Caroline 3
News Will new FDA pediatric cancer drug save lives? (May '15) May '15 jordennancy23 1
More from around the web